CLIENT RESULT

Synthetic mRNA Production Landscape Assessment

Client INDUSTRY
Pharma & Biotech
Stakeholder Interviews
12
mRNA Clinical Trials Analyzed
84
Biopharma Companies Profiled
21
Project Details
capability
Voice-of-Customer Research
capability
Competitive Analysis
capability
Market Landscaping and Sizing

Objective

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

Our Approach

Secondary Research

  • Aggregated secondary research of the therapeutic mRNA space and market demand for manufacturing
  • Summarized key specifications required and demand drivers for external manufacturing
  • Assessed the CMO competitive landscape

‍Primary Research

  • Conducted 12 in-depth stakeholder interviews with biopharma stakeholders with direct experience synthesizing and using mRNA for therapeutic applications
  • Interviewees included experts across public and private biopharma who utilize mRNA for a diverse range of therapeutic applications

Quantitative Analysis

  • Built a bottoms-up model estimating the demand and production level of synthetic mRNA today and in five years within biopharma by application area and phase of development

Outcome

DeciBio shared research findings with the client, key takeaways included:

  • Estimated opportunity for external mRNA manufacturing in 2019 and 2024.
  • Outlined customer requirements and key considerations and recommendations to help inform the client’s acquisition strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch